246 related articles for article (PubMed ID: 25896001)
1. Functional assays for specific targeting and delivery of RNA nanoparticles to brain tumor.
Lee TJ; Haque F; Vieweger M; Yoo JY; Kaur B; Guo P; Croce CM
Methods Mol Biol; 2015; 1297():137-52. PubMed ID: 25896001
[TBL] [Abstract][Full Text] [Related]
2. Methods and assays for specific targeting and delivery of RNA nanoparticles to cancer metastases.
Rychahou P; Shu Y; Haque F; Hu J; Guo P; Evers BM
Methods Mol Biol; 2015; 1297():121-35. PubMed ID: 25896000
[TBL] [Abstract][Full Text] [Related]
3. RNA nanoparticle as a vector for targeted siRNA delivery into glioblastoma mouse model.
Lee TJ; Haque F; Shu D; Yoo JY; Li H; Yokel RA; Horbinski C; Kim TH; Kim SH; Kwon CH; Nakano I; Kaur B; Guo P; Croce CM
Oncotarget; 2015 Jun; 6(17):14766-76. PubMed ID: 25885522
[TBL] [Abstract][Full Text] [Related]
4. Using RNA nanoparticles with thermostable motifs and fluorogenic modules for real-time detection of RNA folding and turnover in prokaryotic and eukaryotic cells.
Zhang H; Pi F; Shu D; Vieweger M; Guo P
Methods Mol Biol; 2015; 1297():95-111. PubMed ID: 25895998
[TBL] [Abstract][Full Text] [Related]
5. Systemic Delivery of Anti-miRNA for Suppression of Triple Negative Breast Cancer Utilizing RNA Nanotechnology.
Shu D; Li H; Shu Y; Xiong G; Carson WE; Haque F; Xu R; Guo P
ACS Nano; 2015 Oct; 9(10):9731-40. PubMed ID: 26387848
[TBL] [Abstract][Full Text] [Related]
6. Fabrication of pRNA nanoparticles to deliver therapeutic RNAs and bioactive compounds into tumor cells.
Shu Y; Shu D; Haque F; Guo P
Nat Protoc; 2013 Sep; 8(9):1635-59. PubMed ID: 23928498
[TBL] [Abstract][Full Text] [Related]
7. Methods for assembling B-cell lymphoma specific and internalizing aptamer-siRNA nanoparticles via the sticky bridge.
Zhou J; Rossi JJ; Shum KT
Methods Mol Biol; 2015; 1297():169-85. PubMed ID: 25896003
[TBL] [Abstract][Full Text] [Related]
8. Fabrication of 14 different RNA nanoparticles for specific tumor targeting without accumulation in normal organs.
Shu Y; Haque F; Shu D; Li W; Zhu Z; Kotb M; Lyubchenko Y; Guo P
RNA; 2013 Jun; 19(6):767-77. PubMed ID: 23604636
[TBL] [Abstract][Full Text] [Related]
9. Specific delivery of therapeutic RNAs to cancer cells via the dimerization mechanism of phi29 motor pRNA.
Guo S; Tschammer N; Mohammed S; Guo P
Hum Gene Ther; 2005 Sep; 16(9):1097-109. PubMed ID: 16149908
[TBL] [Abstract][Full Text] [Related]
10. Assembly of multifunctional phi29 pRNA nanoparticles for specific delivery of siRNA and other therapeutics to targeted cells.
Shu Y; Cinier M; Shu D; Guo P
Methods; 2011 Jun; 54(2):204-14. PubMed ID: 21320601
[TBL] [Abstract][Full Text] [Related]
11. Targeted delivery of cisplatin to prostate cancer cells by aptamer functionalized Pt(IV) prodrug-PLGA-PEG nanoparticles.
Dhar S; Gu FX; Langer R; Farokhzad OC; Lippard SJ
Proc Natl Acad Sci U S A; 2008 Nov; 105(45):17356-61. PubMed ID: 18978032
[TBL] [Abstract][Full Text] [Related]
12. Assembly of therapeutic pRNA-siRNA nanoparticles using bipartite approach.
Shu Y; Cinier M; Fox SR; Ben-Johnathan N; Guo P
Mol Ther; 2011 Jul; 19(7):1304-11. PubMed ID: 21468002
[TBL] [Abstract][Full Text] [Related]
13. Dual functional RNA nanoparticles containing phi29 motor pRNA and anti-gp120 aptamer for cell-type specific delivery and HIV-1 inhibition.
Zhou J; Shu Y; Guo P; Smith DD; Rossi JJ
Methods; 2011 Jun; 54(2):284-94. PubMed ID: 21256218
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of specific delivery of chimeric phi29 pRNA/siRNA nanoparticles to multiple tumor cells.
Li L; Liu J; Diao Z; Shu D; Guo P; Shen G
Mol Biosyst; 2009 Nov; 5(11):1361-8. PubMed ID: 19823753
[TBL] [Abstract][Full Text] [Related]
15. Using Planar Phi29 pRNA Three-Way Junction to Control Size and Shape of RNA Nanoparticles for Biodistribution Profiling in Mice.
Haque F; Xu C; Jasinski DL; Li H; Guo P
Methods Mol Biol; 2017; 1632():359-380. PubMed ID: 28730451
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, conjugation, and labeling of multifunctional pRNA nanoparticles for specific delivery of siRNA, drugs, and other therapeutics to target cells.
Guo P; Shu Y; Binzel D; Cinier M
Methods Mol Biol; 2012; 928():197-219. PubMed ID: 22956144
[TBL] [Abstract][Full Text] [Related]
17. Favorable biodistribution, specific targeting and conditional endosomal escape of RNA nanoparticles in cancer therapy.
Xu C; Haque F; Jasinski DL; Binzel DW; Shu D; Guo P
Cancer Lett; 2018 Feb; 414():57-70. PubMed ID: 28987384
[TBL] [Abstract][Full Text] [Related]
18. Aptamer for imaging and therapeutic targeting of brain tumor glioblastoma.
Delač M; Motaln H; Ulrich H; Lah TT
Cytometry A; 2015 Sep; 87(9):806-16. PubMed ID: 26189784
[TBL] [Abstract][Full Text] [Related]
19. Specific Delivery of MiRNA for High Efficient Inhibition of Prostate Cancer by RNA Nanotechnology.
Binzel DW; Shu Y; Li H; Sun M; Zhang Q; Shu D; Guo B; Guo P
Mol Ther; 2016 Aug; 24(7):1267-77. PubMed ID: 27125502
[TBL] [Abstract][Full Text] [Related]
20. Barcoded nanoparticles for high throughput in vivo discovery of targeted therapeutics.
Dahlman JE; Kauffman KJ; Xing Y; Shaw TE; Mir FF; Dlott CC; Langer R; Anderson DG; Wang ET
Proc Natl Acad Sci U S A; 2017 Feb; 114(8):2060-2065. PubMed ID: 28167778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
